2 years ago-Biopharma Group
2 years ago-BioGenes GmbH

Accelerating Regenerative Medicine Approaches to Type 1 Diabetes Through Direct Cell Reprogramming

Views: 349

Current treatment of type 1 diabetes mellitus (T1DM) depends on the replacement of endogenous insulin by regular subcutaneous injections of exogenous insulin. Unfortunately, exogenous insulin therapy is associated with patient compliance issues and life-threatening hypoglycaemic events. This article by Dr. Lawrence Billing at Mogrify will explore regenerative approaches to resolve T1DM with a focus on how to direct cell reprogramming could influence the field.

Comments: 0

Your email address will not be published. Required fields are marked with *


Your Cart